Pharma

Pharma

COVID-19 pandemic swallows 18% clean energy jobs, stalling years of industry growth, says GlobalData

The clean energy sector had been one of the biggest and fastest-growing sectors in the US since 2015, having employed over 3 million people. However, during March, April, and May, over half a million clean energy workers lost their jobs in the US and filed for unemployment benefits. The total clean energy job loss stands […]

Pharma

COVID-19 disruption of clinical trials starting to slow, says GlobalData

More than 200 trials that were previously disrupted from the COVID-19 pandemic by delayed initiation and slow or suspended enrollment are now ongoing or completed. This represents a 3.2-times increase compared to last month. This upward trend for clinical trial delays may begin to slow further as more companies adjust to conducting clinical trials during […]

Pharma

Moderna’s forecast sales dependent on mRNA-1273 vaccine for COVID-19, says GlobalData

Moderna’s mRNA-1273 vaccine for COVID-19 is currently in Phase I development and is targeted for an aggressive commercial launch in 2021. The vaccine candidate’s peak US sales are currently estimated to reach $17.72B in 2026, meaning mRNA-1273 would account for 90–95% of Moderna’s forecast revenue. As such, mRNA-1273 could be a sales leader for COVID-19, […]

Pharma

Future of over 320 hydroxychloroquine trials is now uncertain, says GlobalData

Following today’s news (Monday 15 June) that the FDA has pulled emergency use authorization of hydroxychloroquine for COVID-19; Johanna Swanson, Product Manager at GlobalData, a leading data and analytics company, offers her view: “GlobalData expects the number of withdrawn or terminated hydroxychloroquine clinical trials will increase in the coming month. This news leaves an uncertain […]

Pharma

Gilead likely preparing for remdesivir approval and launch by ramping up hiring from January to March 2020, says GlobalData

Gilead is likely preparing for remdesivir’s approval and launch, based on an analysis of GlobalData’s Job Analytics database. As an operational reaction to the COVID-19 pandemic, Gilead ramped up hiring from January to March in 2020. However, there was a slight decline in April. Still, this accounted for one of the largest hiring increases in […]

Pharma

MDMA’s efficacy data likely to support FDA approval after studies did not lead to drug abuse, says GlobalData

Following the publication of a new study of the long-term effectiveness of midomafetamine (MDMA) for the treatment of post-traumatic stress disorder (PTSD); Philippa Salter, Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “New long-term data for MDMA as a treatment for PTSD adds to the evidence of the effectiveness of […]

Pharma

COVID-19 accelerates innovations in pharma industry and FDA, says GlobalData

The global COVID-19 pandemic has become a catalyst for the pharma industry and the US Food and Drug Administration (FDA) to implement long-awaited innovations. The urgent manufacturing needs caused by the pandemic and the requirement for social distancing are driving pharma companies and regulators to finally deploy advanced technologies that have been suggested for years […]

Pharma

Delays in Moderna’s COVID-19 vaccine development expected as it looks to be first to market

Moderna Therapeutics recently received Fast-Track designation from the FDA for its COVID-19 candidate vaccine, mRNA-1273 together with the green light to initiate a Phase II clinical trial study. As other candidate vaccines in development have yet to receive Phase II trial approval, mRNA-1273 could be the first vaccine to be approved and launched for COVID-19 treatment, […]

Pharma

New Zealand’s aggressive approach to curb COVID-19 proven very effective strategy, says GlobalData

After a little over 100 days since the first confirmed case of COVID-19 reported on 28 February 2020, New Zealand has lifted almost all restrictions after reporting no active cases in the country. New Zealand’s aggressive approach to curb the spread of the virus has proven to be a very effective strategy as the country […]

Pharma

Generic remdesivir may put pricing pressure on Indian pharma companies, says GlobalData

Following the news that the Indian state of Maharashtra is planning to procure Gilead Sciences’ antiviral drug remdesivir from Bangladesh-based pharmaceutical giant Eskayef Pharmaceuticals; Anupama Mishra, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “Maharashtra is the worst affected state of the COVID-19 outbreak in India. The state has reported […]

Pharma

Over 30 million in the US face healthcare and insurance uncertainty caused by COVID-19

The COVID-19 pandemic has exposed weaknesses around the US healthcare system and resulted in a large amount of uncertainty around the healthcare and health insurance costs for the pandemic, says GlobalData, a leading data and analytics company. As the US does not provide universal healthcare to its citizens, and with more than 30,000,000 citizens who […]

Pharma

Immunotherapies may increase risk of severe COVID-19 in MS patients as total MS drug market in the 7MM set to reach $32.9bn by 2028

COVID-19 presents a challenge to physicians managing patients with multiple sclerosis (MS), due to concerns about using immunotherapies to treat this neurological condition, in the face of the pandemic, says GlobalData, a leading data and analytics company. Immunotherapies are the biggest driver in the MS market and according to GlobalData’s report, ‘Multiple Sclerosis – Global Drug Forecast […]

Pharma

Millions of chloroquine tablets donated by Bayer could be ineffective for treating COVID-19

Bayer donated millions of tablets of chloroquine to national health authorities around the world in anticipation of its possible usage as a treatment for COVID-19. However, these donated tablets may be inadequate for treating COVID-19 due to potential side effects, says GlobalData, a leading data and analytics company. Quentin Horgan, Drugs Database Analyst at GlobalData, […]

Pharma

Effects of COVID19 on pregnancy remain uncertain and debatable, says GlobalData

A recent research study showed that for 16 COVID19 positive women there were evidences that their placentas had blood clots and indications of abnormal blood flow from the mother to the baby with most of the women having normal pregnancies. Though these types of issues are present in women without COVID19 and placentas possess a […]

Pharma

COVID19 has not yet reached its peak in Brazil, says GlobalData

Recently, Brazil has steadily climbed the chart of the top 10 countries with the highest total of COVID19 cases, now ranking number two just behind the US. The epidemiology forecast shows that Brazil has not reached peak and it is likely that the outbreak will continue to worsen there, says GlobalData, a leading data and […]

Pharma

Remdesivir faces challenges from vaccines, says GlobalData

While Gilead Sciences’ remdesivir has been declared the new standard of care for COVID-19 despite some mixed trial results, it will continue to face challenges from vaccines in the pipeline, says GlobalData, a leading data and analytics company. Once a vaccine is developed, the demand for remdesivir to treat COVID-19 patients will decline. Johanna Swanson, […]

Pharma

Five CMOs raise eligibility questions after taking out PPP loans despite remaining open

The news that at least five publicly traded contract manufacturing organizations (CMOs) took out Paycheck Protection Program (PPP) loans from the US Government’s $659bn loan program, despite remaining open for business and despite official guidance that the money was not intended for large public companies, raises questions about the eligibility of the participating companies for […]

Pharma

Over 72% of COVID-19 treatments are at pre-clinical or discovery stages

A large number of COVID-19 treatment options (620 novel and repurposed drugs as of mid-May) have joined the drug development pipeline, with over 72% of these drugs in preclinical or discovery stages of development. These drugs are in the initial stages of feasibility and drug safety investigation to show that they have an effect on […]

Pharma

Outsourced blockbuster drugs manufactured in Spanish facilities could significantly disrupt supply

As of mid-May, there were 131 contract manufacturing organizations (CMOs) in Spain with 161 Spanish sites, according to the GlobalData’s Contract Service Provider database, which details the manufacturing relationships for novel products approved in the US and EU. The company found that the top ten outsourced drugs, by 2019 revenue, that are contract manufactured in […]

Pharma

Hydroxychloroquine’s effectiveness for COVID19 treatment continues to be debated, says GlobalData

There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as […]

Prev 1 … 90 91 92 93 94 … 110 Next

COVID-19 pandemic swallows 18% clean energy jobs, stalling years of industry growth, says GlobalData

COVID-19 disruption of clinical trials starting to slow, says GlobalData

Moderna’s forecast sales dependent on mRNA-1273 vaccine for COVID-19, says GlobalData

Future of over 320 hydroxychloroquine trials is now uncertain, says GlobalData

Gilead likely preparing for remdesivir approval and launch by ramping up hiring from January to March 2020, says GlobalData

MDMA’s efficacy data likely to support FDA approval after studies did not lead to drug abuse, says GlobalData

COVID-19 accelerates innovations in pharma industry and FDA, says GlobalData

Delays in Moderna’s COVID-19 vaccine development expected as it looks to be first to market

New Zealand’s aggressive approach to curb COVID-19 proven very effective strategy, says GlobalData

Generic remdesivir may put pricing pressure on Indian pharma companies, says GlobalData

Over 30 million in the US face healthcare and insurance uncertainty caused by COVID-19

Immunotherapies may increase risk of severe COVID-19 in MS patients as total MS drug market in the 7MM set to reach $32.9bn by 2028

Millions of chloroquine tablets donated by Bayer could be ineffective for treating COVID-19

Effects of COVID19 on pregnancy remain uncertain and debatable, says GlobalData

COVID19 has not yet reached its peak in Brazil, says GlobalData

Remdesivir faces challenges from vaccines, says GlobalData

Five CMOs raise eligibility questions after taking out PPP loans despite remaining open

Over 72% of COVID-19 treatments are at pre-clinical or discovery stages

Outsourced blockbuster drugs manufactured in Spanish facilities could significantly disrupt supply

Hydroxychloroquine’s effectiveness for COVID19 treatment continues to be debated, says GlobalData

Browse

Company information